SLC2A1 and neoplasm: The ginsenoside liposomes not only exerted their inherent antitumor activity by targeting the GLUT on the tumor surface, but also showed significant synergistic effects with PTX by effectively reducing the adsorption of opsonins on the surface of the liposomes, thus improving the structure of the TME, as well as reversing the state of tumor immunodeficiency [26].